Table 1.

AML-specific antibodies derived from patient 101

AntibodyIsotypeSHM VH/VL
AT1413 IgG1κ 26/11 
AT1414 IgG3κ 9/6 
AT1415 IgG3λ 9/9 
AT1416 IgG3λ 9/5 
AT1508 IgG1κ 14/12 
AntibodyIsotypeSHM VH/VL
AT1413 IgG1κ 26/11 
AT1414 IgG3κ 9/6 
AT1415 IgG3λ 9/9 
AT1416 IgG3λ 9/5 
AT1508 IgG1κ 14/12 

SHM, somatic hypermutations; VH, variable heavy domain; VL, variable light domain.

View Large
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal